Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cevira for High-Grade Squamous Intraepithelial Lesions of the Cervix (HSIL)
CTR20201498Phase 3Completed
- Sponsor
- Jiangsu Yahong Meditech
- Start
- Jul 2020
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cevira in cervical intraepithelial neoplasia (CIN), sponsored by Jiangsu Yahong Meditech. Started Jul 2020; status: completed.
02
Drugs
Cevira
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on CTR20201498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201498.